Inclusion of Under-Represented Racial and Ethnic Groups in Cardiovascular Clinical Trials

被引:21
|
作者
Vilcant, Viliane [1 ]
Ceron, Carlos [1 ]
Verma, Gagan [2 ]
Zeltser, Roman [1 ,2 ]
Makaryus, Amgad N. [1 ,2 ]
机构
[1] Nassau Univ Med Ctr, E Meadow, NY 11554 USA
[2] Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY 11549 USA
来源
HEART LUNG AND CIRCULATION | 2022年 / 31卷 / 09期
关键词
Racial minorities; Ethnic minorities; Underrepresentation; Race; Ethnicity; Cardiology; Trials; DISPARITIES; ENROLLMENT; MINORITIES; MORTALITY; HEALTH;
D O I
10.1016/j.hlc.2022.06.668
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Non-White racial and ethnic groups have been traditionally under-represented for decades in the field of cardiology, specifically in cardiovascular research studies. This underrepresentation has occurred despite the fact that these racial and ethnic groups have been shown to be at increased risk of cardiovascular disease (CVD). Methods To assess the trend of representation in mainstream landmark cardiovascular trials, we performed a review of major cardiovascular trials published between 1986 and 2019. Mainstream landmark trials were selected as classified by established cardiology standards. The reported numbers of racial and ethnic participants were assessed within these categorised cardiovascular trials over a continuous time period. Results A total of 1,138,683 patients were assessed from 153 randomised clinical trials. Of these trials, only 56% (n=86) reported information about race. Of note, 99% (n=152) of these trials reported gender. About three-quarters of the trials (77%) were undertaken at least partly in the United States (US). Our results show that the percentage of non-White participants in clinical trials was not significantly different over time (p=0.85), suggesting no significant improvement in non-White racial/ethnic representation. Further analysis of only the US inclusive trials (n=20) also showed no significant improvement in representation (p=0.38). Conclusion Only about half of all major cardiovascular landmark trials reported any racial or ethnic information, despite more recent calls over the last 5-10 years for diversity and representation in cardiovascular research studies. Additionally, no significant improvement in inclusion of traditionally under-represented racial and ethnic groups (UREGs) in these trials has occurred over time. Our analysis shows that there is still major work to be done to foster better representation and evaluation of the UREG population in cardiovascular trials.
引用
收藏
页码:1263 / 1268
页数:6
相关论文
共 50 条
  • [1] Why ethnic minority groups are under-represented in clinical trials: a review of the literature
    Hussain-Gambles, M
    Atkin, K
    Leese, B
    HEALTH & SOCIAL CARE IN THE COMMUNITY, 2004, 12 (05) : 382 - 388
  • [2] Racial and Ethnic Minority Groups Are Under-Represented and Under-Reported in Guideline-Informing Heart Failure Clinical Trials
    Gamino, Gerardo
    Parizo, Justin T.
    Scheinker, David
    Rodriguez, Fatima
    CIRCULATION, 2020, 142
  • [3] The willingness of under-represented groups to participate in clinical trials
    Peterson, ED
    Lytle, BL
    Alexander, KR
    Coombs, LP
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 435A - 435A
  • [4] Are elderly and women under-represented in cardiovascular clinical trials? Implication for treatment
    Cristiana Vitale
    Giuseppe Rosano
    Massimo Fini
    Wiener klinische Wochenschrift, 2016, 128 : 433 - 438
  • [5] Are elderly and women under-represented in cardiovascular clinical trials? Implication for treatment
    Vitale, Cristiana
    Rosano, Giuseppe
    Fini, Massimo
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : 433 - 438
  • [6] Inclusion of Under- represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease
    Cohen, Nathaniel A.
    Silfen, Alexa
    Rubin, David T.
    GASTROENTEROLOGY, 2022, 162 (01) : 17 - 21
  • [8] The elderly were under-represented in osteoarthritis clinical trials
    Liberopoulos, George
    Trikalinos, Nikolaos A.
    Ioannidis, John P. A.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2009, 62 (11) : 1218 - 1223
  • [9] Women and elderly: subgroups under-represented in clinical trials
    Devlin, Gerard
    CURRENT OPINION IN CARDIOLOGY, 2010, 25 (04) : 335 - 339
  • [10] Recruitment and Retention of Under-Represented Groups with Health Disparities into Clinical Trials: A Formative Approach
    Rosanne Harrigan
    Michael H. Perez
    Steven Beaudry
    Crystal Johnson
    Payel Sil
    Kau’ionālani Mead
    Noelani Apau-Ludlum
    Journal of Immigrant and Minority Health, 2014, 16 : 898 - 903